Participate in a free CME/CE/CPE webinar derived from our in-person Myeloma Rounds held on March 6, 2018 in Philadelphia, PA and April 18, 2018 in Hollywood, FL.
To receive continuing education (CE) credit, you must complete the virtual lecture, CE posttest and activity evaluation.
1.25 CE Credits Available Until: August 29, 2019
This activity has been designed to meet the educational needs of hematologists-oncologists, oncologists, pharmacists, physician assistants, nurse practitioners, and oncology nurses involved in the care of patients with multiple myeloma.
At the conclusion of this program, participants will be able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in clinical trial discussions on newly approved therapies and emerging therapies for myeloma
- Identify strategies for optimal patient care
- Apply evidence-based treatment strategies
Edward A. Stadtmauer, MD (Chair)
Section Chief, Hematologic Malignancies
Roseman, Tarte, Harrow, and Shaffer Families’ President’s Distinguished Professor
University of Pennsylvania Abramson Cancer Center
James E. Hoffman, MD (Chair)
Assistant Professor of Clinical Medicine
Director, SDG for Multiple Myeloma
Plasma Cell Diseases
Sylvester Comprehensive Cancer Center
University of Miami Health System
Jointly provided by The Leukemia & Lymphoma Society, Albert Einstein College of Medicine, and Medical Learning Institute, Inc.
Sponsors and Supports:
This activity is supported by educational grants from AbbVie Inc., Amgen Inc., Celgene Corporation and Takeda Oncology.